A recent study found that rimegepant, an orally administered calcitonin gene-related peptide receptor antagonist, is safe and well-tolerated for up to 52 weeks in individuals with migraine, with no signs of...
Researchers studied the effect of blueberries, a food known to fight diabetes and cardiovascular disease, on the risk of neurodegenerative disorders in a new study.
